Join one of Canada's top R&D investors on Monday, November 26, at the Centre Sheraton Montréal
KIRKLAND, QC, Nov. 22, 2012 /CNW Telbec/ - Members of the media are invited to attend a press conference during which a multi-million dollar investment towards the growth of the life sciences research sector in Montréal will be announced in the company of: Cyril Schiever, President and Managing Director, Merck Canada Inc.; Martin Leblanc, Vice-Chairman of the Board, Montréal InVivo; Dr. Vassilios Papadopoulos, Executive Director and Chief Scientific Officer, Research Institute of the McGill University Health Centre (RI-MUHC); Dr. Jacques Turgeon, Director, CRCHUM and Dr. Jean-Claude Tardif, Director, Montréal Heart Institute Research Centre. The press conference will be followed by a round table featuring Montréal's next generation of researchers.
| WHEN: | Monday, November 26th, 2012 at 10:00 a.m. | |
| 10:00 a.m. | Press conference begins | |
| 10:30 a.m. | Q&A | |
| 10:40 a.m. | One-on-one interviews and photo opportunity | |
| 11:15 a.m. | Round table discussion with Montréal's next generation of researchers | |
| 12:30 p.m. | Lunch | |
| WHERE: | Centre Sheraton Montréal | |
| 1201 Rene-Levesque West Blvd., Montréal, H3B 2L7 | ||
| Drummond Room | ||
SOURCE: MERCK
Stephanie Lyttle
514-843-2365
514-501-8685 (cell)
[email protected]
Share this article